Search
for
Sort by
Research 151–180 of 1000+
- Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng
- Apoptosis and cutaneous biology
- A position effect on TRPS1 is associated with Ambras syndrome in humans and the Koala phenotype in mice
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Melatonin promotes secondary hair follicle development of early postnatal cashmere goat and improves cashmere quantity and quality by enhancing antioxidant capacity and suppressing apoptosis
- To grow or not to grow: Hair morphogenesis and human genetic hair disorders
- Evidence-based approach to cutaneous hyperandrogenism in women
- Study of<i>Demodex</i>mites: Challenges and Solutions
- Photobiomodulation of human dermal fibroblasts in vitro: decisive role of cell culture conditions and treatment protocols on experimental outcome
- Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor
- Interventions for female pattern hair loss
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Cell wall-associated ROOT HAIR SPECIFIC 10, a proline-rich receptor-like kinase, is a negative modulator of Arabidopsis root hair growth
- Exogenous calreticulin improves diabetic wound healing
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Polycystic ovary syndrome: A review for dermatologists
- Removing all obstacles: A critical role for p53 in promoting tissue renewal
- Women's midlife health Reframing menopause
- Responses of hair follicle–associated structures to loss of planar cell polarity signaling
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Obesity and the Polycystic Ovary Syndrome
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Androgen antagonists in androgen target tissues
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Optimization of menthol-loaded nanocapsules for skin application using the response surface methodology
- Contraceptive implant use among inner city teens
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- Injectable “Skin Boosters” in Aging Skin Rejuvenation: A Current Overview
- Emerging Therapies for Acne Vulgaris